Andreas Adam
Papers
1
Total Citations
62
H-Index
1
About
Andreas Adam is a leading figure in interventional oncology and urologic radiology, whose work has significantly advanced the minimally invasive treatment of renal cell carcinoma. His research focuses on comparing the efficacy of percutaneous ablation techniques with surgical approaches, particularly for small renal tumors. In his highly cited 2016 study, Adam conducted a pivotal retrospective analysis at a high-volume tertiary center, directly comparing the oncologic outcomes of percutaneous radiofrequency ablation (RFA) against robotic-assisted partial nephrectomy (RPN) for T1 stage renal cancer. This work, which has garnered over 60 citations, provided crucial evidence on the comparative effectiveness of these two treatment modalities, helping to guide clinical decision-making for patients with small renal masses. By rigorously evaluating the trade-offs between a non-invasive, image-guided procedure and a robotic surgical approach, Adam has contributed to the broader shift toward personalized, less invasive cancer care. His research remains essential reading for interventional radiologists and urologic surgeons seeking to optimize patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1